Breedlove Robert Charles
- SEC CIK
- 0002066645
In the past year, 1 open-market sale filing worth $7.08K and no purchases.
Current role at each company
- PHAT Phathom Pharmaceuticals, Inc.Principal Accounting Officeras of Sep 8, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $7.08K
- 1 filing
- Net
- −$7.08K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Breedlove Robert Charles as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 5, 2025 (view filing) | Nov 3 | 2 days | Breedlove Robert CharlesPrincipal Accounting Officer | SSale | −524 | $13.51 | −$7.08K | −1.1%47.4K after | |
| Sep 9, 2025 (view filing) | Sep 5 | 4 days | Breedlove Robert CharlesPrincipal Accounting Officer | SSale | −461 | $12.09 | −$5.57K | −1.0%47.9K after | |
| Jul 18, 2025 (view filing) | Jul 16 | 2 days | Breedlove Robert CharlesPrincipal Accounting Officer | SSale | −1.69K | $8.36 | −$14.1K | −3.4%48.4K after |